Aduro BioTech Obtains $119,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9b7997b0-033e-4bb2-948a-687532fe308a
Date
4/15/2015
Company Name
Aduro BioTech
Mailing Address
626 Bancroft Way Berkeley, CA 94710 USA
Company Description
Aduro BioTech (NASDAQ: ADRO) is an immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases.
Website
http://www.adurobiotech.com
Transaction Type
IPO
Transaction Amount
$119,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC.
M&A Terms